Foghorn Therapeutics (FHTX) Leases (2020 - 2025)
Historic Leases for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $10.2 million.
- Foghorn Therapeutics' Leases fell 5771.32% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 5771.32%. This contributed to the annual value of $22.6 million for FY2024, which is 2441.91% down from last year.
- Per Foghorn Therapeutics' latest filing, its Leases stood at $10.2 million for Q3 2025, which was down 5771.32% from $10.9 million recorded in Q2 2025.
- Over the past 5 years, Foghorn Therapeutics' Leases peaked at $40.7 million during Q2 2021, and registered a low of $400000.0 during Q1 2021.
- For the 5-year period, Foghorn Therapeutics' Leases averaged around $28.0 million, with its median value being $31.4 million (2023).
- Per our database at Business Quant, Foghorn Therapeutics' Leases soared by 925050.0% in 2022 and then crashed by 5771.32% in 2025.
- Over the past 5 years, Foghorn Therapeutics' Leases (Quarter) stood at $38.5 million in 2021, then fell by 11.5% to $34.1 million in 2022, then decreased by 12.12% to $30.0 million in 2023, then fell by 24.42% to $22.6 million in 2024, then plummeted by 55.05% to $10.2 million in 2025.
- Its Leases stands at $10.2 million for Q3 2025, versus $10.9 million for Q2 2025 and $21.2 million for Q1 2025.